Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Go back to Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
(NASDAQ: RXRX) Delayed: 3.83 +0.29 (8.19%)
Previous Close $3.54    52 Week High
Open $3.54    52 Week Low
Day High $3.83    P/E N/A 
Day Low $3.50    EPS
Volume 44,293,725       

(NASDAQ: RXRX) Delayed: 3.83 +0.29 (8.19%)
Previous Close $3.54    52 Week High
Open $3.54    52 Week Low
Day High $3.83    P/E N/A 
Day Low $3.50    EPS
Volume 44,293,725